)
)
Y-mAbs Therapeutics Inc Investor Relations Material
Latest events
Q4 2024
Y-mAbs Therapeutics Inc
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Y-mAbs Therapeutics Inc
Access all reports
Y-mAbs Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of antibody-based therapies for the treatment of cancer. The company specializes in creating monoclonal antibody treatments that target tumors in pediatric and adult patients. Y-mAbs leverages its expertise in immunotherapies to advance a pipeline of innovative treatments designed to improve survival rates and patient outcomes in oncology. Its focus is primarily on addressing rare and difficult-to-treat cancers. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Key slides for Y-mAbs Therapeutics Inc
Corporate Presentation
Y-mAbs Therapeutics Inc
Corporate Presentation
Y-mAbs Therapeutics Inc
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
YMAB
Country
🇺🇸 United States